Lv1
36 积分 2024-06-26 加入
Missing the target in cancer therapy
25天前
已完结
China’s innovation in translational medicine: rethinking early-stage clinical development
1个月前
已完结
Approvals by the China NMPA in 2025
1个月前
已完结
Trends in target novelty in oncology R&D
1个月前
已完结
DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks
3个月前
已完结
Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8+ T cells in hepatocellular carcinoma
4个月前
已完结
EZH2-mediated development of therapeutic resistance in cancer
4个月前
已完结
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
4个月前
已完结
PDX models for functional precision oncology and discovery science
4个月前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
4个月前
已完结
皖公网安备34019202002308
